The National Diabetes Authority in Libya has announced the arrival of three consecutive shipments of insulin, with additional shipments en route to the country. Authority head Awad Al-Qaweri confirmed that distribution will be exclusive to patients previously registered in the electronic system. This move aims to regulate distribution and ensure transparency and fairness in allocating available quantities. The authority is working to stabilize the country's insulin supply.
According to Al-Qaweri, further insulin shipments are currently being transported and are expected to arrive in the near future. This development is expected to help guarantee continued treatment for patients. The authority is coordinating with the Medical Supply Device to import required shipments, ensuring they are delivered according to legal procedures and approved health conditions. Patients are advised to undergo regular medical check-ups to monitor their health and determine suitable dosages.
The National Diabetes Authority is working to provide for the needs of diabetes patients in Libya. Al-Qaweri emphasized the authority's commitment to organizing medication distribution and prioritizing patient health. The authority is registered patients in the electronic system to ensure they receive their medication. This approach aims to prevent shortages and ensure equal access to insulin for all registered patients.
The electronic system was established to manage insulin distribution efficiently. Registered patients will be able to access their medication through this system. The authority is urging patients to adhere to their scheduled medical appointments and follow recommended treatment plans. By doing so, patients can manage their condition effectively and prevent complications.
Additional insulin shipments are expected to arrive in Libya shortly. The National Diabetes Authority is working closely with relevant parties to ensure a stable insulin supply. Patients are advised to remain calm and follow the authority's instructions regarding medication collection. The authority is committed to providing updates on the insulin supply and distribution.
The National Diabetes Authority's efforts aim to address the insulin shortage in Libya. By organizing distribution and ensuring transparency, the authority hopes to alleviate concerns among diabetes patients. The authority's work will continue to focus on providing for patients' needs and maintaining a stable medication supply.
The Libyan government and relevant health authorities will continue to monitor the situation and provide support to the National Diabetes Authority. Patients can access information and updates through official channels. The authority appreciates the cooperation of patients and medical professionals in managing the insulin supply.
Key points
- The National Diabetes Authority in Libya receives three consecutive insulin shipments.
- Distribution will be exclusive to patients previously registered in the electronic system.
- Additional insulin shipments are en route to the country, expected to arrive shortly.
